Novavax

Novavax confident Covid vaccine will receive FDA authorization in June after delays

Novavax confident Covid vaccine will receive FDA authorization in June after delays

Novavax is confident its Covid-19 vaccine will receive the endorsement of the Food and Drug Administration’s advisory committee early this summer, executives said this week. The FDA committee is scheduled to meet on June 7 to review Novavax’s submission. An endorsement from the committee, which is made up of independent experts, would mean the drug …

Novavax confident Covid vaccine will receive FDA authorization in June after delays Read More »

Novavax Reports First Quarter 2022 Financial Results and Operational Highlights

Novavax Reports First Quarter 2022 Financial Results and Operational Highlights

Achieved revenue of $704 million and net income of $203 million highlighting the first profitable quarter as a commercial stage company Reiterating full year 2022 total revenue guidance of between $4 and $5 billion Continued label expansion including primary, booster and adolescent authorizations and new shipments of Nuvaxovid™ into European Union, Canada, South Korea, Australia …

Novavax Reports First Quarter 2022 Financial Results and Operational Highlights Read More »